Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment

BACKGROUND: Pancreatic cancer is one of the most lethal type of cancers, with an overall five-year survival rate of less than 5%. It is usually diagnosed at an advanced stage with limited therapeutic options. To date, no effective treatment options have demonstrated long-term benefits in advanced pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Looi, Chin-King, Chung, Felicia Fei-Lei, Leong, Chee-Onn, Wong, Shew-Fung, Rosli, Rozita, Mai, Chun-Wai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463646/
https://www.ncbi.nlm.nih.gov/pubmed/30987642
http://dx.doi.org/10.1186/s13046-019-1153-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463646/
https://www.ncbi.nlm.nih.gov/pubmed/30987642
http://dx.doi.org/10.1186/s13046-019-1153-8

Ejemplares similares